Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PSMB8 | P28062 | 2/20 | 0.35 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | MGLL | Q99685 | 3/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.32 |
| ▸ | PARL | Q9H300 | 1/20 | 0.31 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.31 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.31 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | ATM | Q13315 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31522720 | 0.98 | PSMB8 (0.34) | PSMB8PSMB5LMNAMGLLKMT2A | |
| Ethylene Glycol SCHEMBL999673 | 0.94 | PSMB8 (0.36) | PSMB8PSMB5LMNAMGLL | |
| SCHEMBL14644916 | 0.94 | PSMB8 (0.33) | PSMB8PSMB5LMNAMGLLTSHR | |
| SCHEMBL2263421 | 0.94 | MGLL (0.35) | PSMB8PSMB5LMNAMGLL | |
| SCHEMBL6812766 | 0.92 | PSMB8 (0.33) | PSMB8PSMB5LMNAMGLLPARL | |
| SCHEMBL43575 | 0.92 | EGLN1 (0.36) | PSMB8PSMB5LMNAMGLLKMT2A | |
| SCHEMBL22777675 | 0.91 | SMN1; SMN2 (0.36) | PSMB8PSMB5LMNAMGLLKMT2A | |
| SCHEMBL290461 | 0.91 | SMN1; SMN2 (0.40) | PSMB8PSMB5LMNAMGLLKMT2A | |
| SCHEMBL34383 | 0.91 | SMN1; SMN2 (0.36) | PSMB8PSMB5LMNAMGLLKMT2A | |
| SCHEMBL2454952 | 0.90 | TSHR (0.50) | PSMB8PSMB5LMNAKMT2ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 6379 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12629445-B2 | Reactive hydrogel forming formulations and related methods, including methods of preparation | BARD PERIPHERAL VASCULAR, INC. (US) | 2026-05-19 | — | — | US | claimed |
| EP-4104853-B1 | ARGININE DEIMINASE WITH REDUCED CROSS-REACTIVITY TOWARD ADI - PEG 20 ANTIBODIES FOR CANCER TREATMENT | POLARIS GROUP (KY) | 2026-05-06 | — | — | EP | claimed |
| EP-4683964-A2 | POLY(ETHYLENE GLYCOL) BASED DENDRIMER-LIKE HYPERBRANCHED MACROMOLECULES, METHODS OF PREPARATION AND USE THEREOF | Ocular Therapeutix, Inc. (US) | 2026-01-28 | — | — | EP | claimed |
| EP-4665307-A1 | BIODEGRADABLE MICROPARTICLES FOR SUSTAINED DRUG DELIVERY, METHODS OF PREPARATION AND USE THEREOF | Ocular Therapeutix, Inc. (US) | 2025-12-24 | — | — | EP | claimed |
| EP-4667566-A1 | ARGININE DEIMINASE MUTANT, COVALENT DIMER AND CONJUGATE AND USE THEREOF | Peg-Bio Biopharm Co., Ltd. (Chongqing) (CN) | 2025-12-24 | — | — | EP | claimed |
| WO-2025226837-A1 | ANTI-BACTERIAL METALLOTHIONEIN ANTIBODIES AND USES THEREOF | UNIVERSITY OF CONNECTICUT (US) | 2025-10-30 | — | — | WO | claimed |
| EP-4630058-A2 | CHEMICAL TISSUE ABLATION WITH HYDROGEL MATRIX AND CORRESPONDING MEDICAL APPLICATIONS | Pramand LLC (US) | 2025-10-15 | — | — | EP | claimed |
| US-20250295792-A1 | POLYETHYLENE GLYCOL-MODIFIED FORM OF KININ OR DERIVATIVE THEREOF AND PHARMACEUTICAL USE THEREOF | ZONHON BIOPHARMA INSTITUTE, INC. (CN) | 2025-09-25 | — | — | US | claimed |
| EP-4582090-A2 | COMPOSITION COMPRISING PEGYLATED ARGININE DEIMINASE | Polaris Group (TW) | 2025-07-09 | — | — | EP | claimed |
| US-20250215414-A1 | COMBINATION CANCER IMMUNOTHERAPIES WITH ARGININE DEPLETION AGENTS | POLARIS GROUP (KY) | 2025-07-03 | — | — | US | claimed |
| WO-1998039464-A2 | ADENOVIRUS VECTORS CONTAINING HETEROLOGOUS TRANSCRIPTION REGULATORY ELEMENTS AND METHODS OF USING SAME | CELL GENESYS, INC. (US) | 1998-09-11 | — | — | WO | claimed |
| US-5711944-A | Interferon polymer conjugates | ENZON, INC. (US) | 1998-01-27 | — | — | US | claimed |
| EP-0730470-A1 | IMPROVED INTERFERON POLYMER CONJUGATES | ENZON, INC. (US) | 1996-09-11 | — | — | EP | claimed |
| CN-1126441-A | Amplification of vitamin B12 absorption System Using polymers | BIOTECH AUSTRALIA PTY LTD (AU) | 1996-07-10 | — | — | CN | claimed |
| WO-1995013090-A1 | IMPROVED INTERFERON POLYMER CONJUGATES | ENZON, INC. (US) | 1995-05-18 | — | — | WO | claimed |
| US-5264209-A | Polyoxyethylene glycol modified interleukin derivative for hematopoietic disorders and thrombocytopenia | KIRIN-AMGEN, INC. (US) | 1993-11-23 | — | — | US | claimed |
| EP-0442724-A2 | Modified hIL-6 | Kirin-Amgen, Inc. (US) | 1991-08-21 | — | — | EP | claimed |
| US-4608246-A | Testing for a blood group immunological reaction | IMMUCOR, INC. (US) | 1986-08-26 | — | — | US | claimed |
| EP-0157797-A1 | DETECTING AN IMMUNOLOGICAL REACTION WITH ACTIVATED RED BLOOD CELLS (ERYTHROCYTES) | IMMUCOR, INC. (US) | 1985-10-16 | — | — | EP | claimed |
| WO-1985001354-A1 | DETECTING AN IMMUNOLOGICAL REACTION WITH ACTIVATED RED BLOOD CELLS (ERYTHROCYTES) | IMMUCOR, INC. (US) | 1985-03-28 | — | — | WO | claimed |